This Ri.MED Symposium will bring together a panel of scientists for a two-day virtual meeting and it will cover various complementary approaches focused on COVID-19.
The first day will focused on drug discovery, from advanced data analysis to structural biology approaches, while the second one will be clinical focused, including clinical research programs and trials, along with a case-history of IRCCS ISMETT during the SARS-CoV-2 pandemic in Sicily.
WEDNESDAY, 23 JUNE 2021 – 2:15 pm CET – 6:00 pm CET
KEYNOTE LECTURE – Rolf Hilgenfeld, PhD, Director, Institute of Biochemistry, University of Luebeck; German Center for Infection Research (DZIF), Braunschweig, Germany
Ugo Perricone, PhD, Group Leader, Molecular Informatics Group, Fondazione Ri.MED, Palermo, Italy
Mathias Munschauer, PhD, Junior Group Leader, Helmholtz Institute for RNA-based Infection Research, Würzburg, Germany
Claudia Coronnello, PhD, Senior Scientist in Computational Biology, Advanced Data Analysis Group, Fondazione Ri.MED, Palermo, Italy
Andreas Schlundt, PhD, Group Leader, Institute of Molecular Biosciences and Biomagnetic Resonance Center (BMRZ), Goethe University Frankfurt, Germany
Caterina Alfano, PhD, Group Leader, Structural Biology and Biophysics Group, Fondazione Ri.MED, Palermo, Italy
THURSDAY, 24 JUNE 2021 – 2:15 pm CET – 6:00 pm CET
KEYNOTE LECTURE – Andrea Gambotto, MD, Associate Professor of Surgery, University of Pittsburgh, USA
Giovanna Panarello, MD, Chief of Intensive Care Unit, IRCCS ISMETT, Palermo, Italy
Camillo Ricordi, MD, PhD, Stacy Joy Goodman Professor of Surgery, Distinguished Professor of Medicine, Director of the Diabetes Research Institute (DRI), Director of the Cell Transplant Program, University of Miami, USA and Giacomo Lanzoni, Ph.D., Research Assistant Professor, Diabetes Research Institute, Cell Transplant Center, University of Miami
Albert Comelli, PhD, Scientist in Nuclear Magnetic Resonance, Advanced Data Analysis Group, Fondazione Ri.MED, Palermo, Italy
Anthony R. Cillo, PhD, Postdoctoral Associate, Department of Immunology, University of Pittsburgh, USA
Monica Miele, PhD, GMP Production Manager, Fondazione Ri.MED and Matteo Bulati, PhD, Senior Scientis in Immunology, IRCCS ISMETT, Palermo, Italy